Leukocyte adhesion deficiency type I is a rare inherited immune disorder that usually becomes clear in infancy or early childhood. People with leukocyte adhesion deficiency type I often have repeated bacterial infections, slow wound healing, and little or no pus at infected areas, and the early signs of leukocyte adhesion deficiency type I can include delayed separation of the umbilical cord. It may help to know that doctors have studied this condition for decades, and not everyone will have the same experience. Leukocyte adhesion deficiency type I is lifelong, and severe cases can be life-threatening without treatment because serious infections can keep coming back. Treatment focuses on preventing and quickly treating infections, and some children with severe leukocyte adhesion deficiency type I may be treated with a stem cell transplant.
How many people live with Leukocyte adhesion deficiency type i?
Orphanet lists leukocyte adhesion deficiency type I as affecting fewer than 1 person in 1,000,000, which suggests fewer than about 8,200 people worldwide (Orphanet, 2024; United Nations, 2024). Using that same rate, fewer than about 350 people may be living with it in the United States, but this is a rough estimate rather than a direct count (Orphanet, 2024; U.S. Census Bureau, 2024).
Overview
Leukocyte adhesion deficiency type iSymptoms
Leukocyte adhesion deficiency type I often causes repeated bacterial infections, slow wound healing, and little or no pus. Early signs of Leukocyte adhesion deficiency type I can include delayed umbilical cord separation and severe gum disease.
Outlook and prognosis
With early diagnosis and regular specialist care, many people with leukocyte adhesion deficiency type 1 can live longer, healthier lives. Prognosis depends largely on infection control. Stem cell transplant can be life-changing for some children.
Causes and risk factors
Leukocyte adhesion deficiency type I is caused by changes in the ITGB2 gene. It is inherited in an autosomal recessive pattern, meaning both parents usually carry one changed copy. Lifestyle or environmental factors do not cause it.
Genetic influences
Genetics are central to Leukocyte adhesion deficiency type I. It is caused by changes in the ITGB2 gene, and the exact variant can influence how severe symptoms are and help guide genetic testing and family counseling.
Diagnosis
Doctors suspect leukocyte adhesion deficiency type i from clinical features such as delayed umbilical cord separation, repeated serious infections, and poor wound healing. Diagnosis is confirmed with blood tests showing very low CD18 on white blood cells and genetic tests.
Treatment and drugs
Treatment for leukocyte adhesion deficiency type I focuses on preventing and quickly treating infections. Many living with leukocyte adhesion deficiency type I need antibiotics, careful wound care, and sometimes white blood cell transfusions. Stem cell transplant can be life-changing for some children.
Symptoms
Leukocyte adhesion deficiency type I can show up early in life as infections that keep coming back and wounds that heal slowly. Because certain white blood cells cannot move well from the blood into tissues, the body may struggle to fight germs where they enter, especially in the skin, gums, and around the belly button after birth. The early features of Leukocyte adhesion deficiency type I often appear in infancy, although milder forms may become clearer later in childhood. Symptoms vary from person to person and can change over time.
The umbilical cord may stay attached longer than usual after birth, sometimes for more than 3 weeks. The skin around it can also become red, irritated, or infected.
People with Leukocyte adhesion deficiency type I often have repeated bacterial infections, especially in the skin and soft tissues. These infections can be unusually severe or come back soon after treatment.
Infected areas may look red, warm, swollen, or painful but produce very little pus. This happens because infection-fighting cells have trouble reaching the tissue.
Cuts, sores, and surgical wounds may take longer than expected to heal. In daily routines, this might show up as a minor scrape or mouth sore that stays inflamed for days or weeks.
How people usually first notice Leukocyte adhesion deficiency type i?
Leukocyte adhesion deficiency type I is often first noticed in early infancy, when a baby has delayed separation of the umbilical cord, often later than 3 to 4 weeks, along with repeated bacterial skin or soft tissue infections. Many living with this condition have infections that seem unusually severe but produce little or no pus, and doctors may also notice poor wound healing, inflamed gums, or very high white blood cell counts on routine blood tests. In other words, the first signs of leukocyte adhesion deficiency type I are usually a pattern of early, hard-to-control infections rather than a single unique symptom, which is why these early clues often lead families and doctors to genetic testing.
Types of Leukocyte adhesion deficiency type i
No distinct types of Leukocyte adhesion deficiency type I are widely recognized.
Can I slow down the onset of symptoms?
No. Because leukocyte adhesion deficiency type 1 is an inherited immune system condition that is present from birth, there is no good evidence that lifestyle changes like diet, exercise, sleep, or vitamins can meaningfully delay when symptoms start. Early care from an immune specialist can still help by preventing and treating infections as quickly as possible, and for some children a stem cell transplant is the main treatment; this cannot guarantee a certain outcome, but early expert care can make an important difference.
What genetics can tell you about symptoms
Genetics can explain a lot about symptoms in leukocyte adhesion deficiency type I because different changes in the gene involved can affect how well white blood cells move out of the bloodstream and into tissues to fight infection. In general, variants that leave very little gene function are linked with symptoms that start earlier and tend to be more severe, such as repeated serious bacterial infections, poor wound healing, delayed separation of the umbilical cord, and little or no pus at infected sites, while variants that allow some function may lead to milder symptoms or a later diagnosis. Even so, symptoms can still vary from one person to another, so genetics helps estimate the likely pattern but does not predict every detail.
Causes and risk factors
Leukocyte adhesion deficiency type I is caused by changes in the ITGB2 gene, and these changes are usually inherited from both parents. A child usually develops it only when they inherit a nonworking copy from each parent, so family history is one of the main risk factors for leukocyte adhesion deficiency type I. The chance is also higher when both parents are carriers or when the parents are related to each other. Lifestyle and environment do not cause leukocyte adhesion deficiency type I, but infections and other physical stresses can affect when symptoms show up and how severe they seem. Genetic testing can sometimes clarify your personal risk.
What are the most common causes or risk factors?
Leukocyte adhesion deficiency type I is almost always caused by an inherited change in a gene called ITGB2, which keeps white blood cells from sticking to blood vessel walls and moving into infected tissue the way they should. The main risk factor is family history: a child usually develops it only if they inherit one changed copy of the gene from each parent, even when the parents are healthy themselves. It can also be more likely when the parents are blood relatives, and there are no known lifestyle or environmental causes.
Environmental and biological risk factors
Known environmental and biological risk factors for leukocyte adhesion deficiency type I are very limited. Doctors often group risks into internal (biological) and external (environmental). For this condition, no well-established environmental exposures or non-genetic biological factors have been shown to increase the chance of being born with it.
No well-established exposure in the home, workplace, or general environment has been shown to cause leukocyte adhesion deficiency type I. This includes common pollutants, household chemicals, and everyday infections around the mother during pregnancy.
Maternal diabetes, high blood pressure, or most routine illnesses in pregnancy are not known causes of this condition. Current evidence has not shown that usual pregnancy stress or minor infections raise the chance of it occurring.
Advanced maternal or paternal age is not a recognized risk factor here. This differs from some congenital conditions where age at conception can clearly change risk.
Premature delivery, low birth weight, or complications during labor do not create this condition. It is present from birth rather than being caused by events during delivery or newborn care.
Genetic risk factors
When families ask about the genetic causes of leukocyte adhesion deficiency type I, the main issue is a change in the ITGB2 gene. The condition develops when both copies of this gene are not working properly, which keeps white blood cells from reaching sites of infection the way they should. Some risk factors are inherited through our genes, and for this condition the biggest one is having two carrier parents.
ITGB2 changes: Leukocyte adhesion deficiency type I happens when both copies of the ITGB2 gene have disease-causing changes. This gene makes CD18, a protein white blood cells need to move out of the blood and into infected tissue.
Recessive inheritance: Leukocyte adhesion deficiency type I is inherited in an autosomal recessive pattern. This means a child usually receives one nonworking ITGB2 copy from each parent.
Carrier parents: Parents with one changed ITGB2 copy are usually healthy carriers because their other copy still works. If both parents are carriers, each pregnancy has a 25% chance of a child with the condition, a 50% chance of a carrier child, and a 25% chance of a child with two working copies.
Family history: Having a brother, sister, or close relative with leukocyte adhesion deficiency type I raises the chance that others in the family may carry the same gene change. This is why families may be offered carrier testing or genetic counseling.
Related parents: The chance of this condition is higher when parents are biologically related, such as cousins. Relatives are more likely to carry the same rare ITGB2 variant and pass two changed copies to a child.
CD18 amount: Different ITGB2 changes can leave very low or slightly higher amounts of CD18 on white blood cells. In general, lower CD18 levels are linked with earlier and more severe symptoms.
Lifestyle risk factors
Leukocyte adhesion deficiency type I is an inherited immune disorder, so lifestyle habits do not cause it. Still, how lifestyle affects leukocyte adhesion deficiency type I can matter because daily routines may influence infection risk, wound healing, mouth health, and overall resilience. The most helpful focus is on habits that reduce exposure to germs and support consistent care.
Poor brushing and flossing can worsen severe gum inflammation and early tooth loss, which are common problems in leukocyte adhesion deficiency type I. Careful daily mouth care and regular dental follow-up may lower bacterial buildup and help limit painful oral infections.
Cuts, scrapes, and irritated skin can become sites of recurrent bacterial infection and slow healing in leukocyte adhesion deficiency type I. Gentle skin care, prompt cleaning of minor wounds, and avoiding skin picking can help reduce complications.
Undercooked foods, unpasteurized products, and unsafe food handling can increase exposure to harmful bacteria in someone whose white blood cells have trouble reaching infected tissue. Good food hygiene may lower the chance of gastrointestinal or systemic infections.
Regular, moderate exercise does not correct the immune defect, but it can support strength, mobility, and recovery during periods of chronic illness. Overexertion during active infection or poor healing periods may increase fatigue and make symptoms harder to manage.
Risk prevention
Leukocyte adhesion deficiency type I is an inherited immune system condition, so the condition itself usually cannot be prevented if someone is born with it. For many living with leukocyte adhesion deficiency type I, prevention means lowering the risk of serious infections, poor wound healing, and other complications through daily care and close medical follow-up. Some prevention is universal, others are tailored to people with specific risks. Early action matters, especially if there are early symptoms of leukocyte adhesion deficiency type I such as repeated skin infections, slow healing, or ongoing mouth sores.
Careful handwashing, clean wound care, and good dental hygiene can help lower the chance of infections in people with leukocyte adhesion deficiency type I. Small cuts, gum irritation, or skin redness should be treated early because infections can worsen quickly.
Ongoing follow-up with an immunology team helps catch problems before they become severe in leukocyte adhesion deficiency type I. Prevention works best when combined with regular check-ups.
Household members should stay up to date on recommended vaccines to reduce the chance of bringing infections home. The vaccine plan for someone with leukocyte adhesion deficiency type I should be individualized by their specialist, because not every vaccine is appropriate in every situation.
Doctors may recommend rapid treatment for suspected infections, and some people with leukocyte adhesion deficiency type I may also need preventive antibiotics. This can reduce the risk of deeper infections and hospital stays.
Can you prevent Leukocyte adhesion deficiency type i?
No, leukocyte adhesion deficiency type 1 usually cannot be prevented because it is an inherited condition that a child is born with. If it runs in your family, meeting with a genetics specialist before pregnancy can help you understand the chance of passing it on and what testing options are available. While that does not prevent the condition in someone who has it, early diagnosis and careful infection prevention can help lower the risk of serious complications.
Transmission
Leukocyte adhesion deficiency type I is not infectious, so it does not spread from person to person through coughing, kissing, blood, food, or everyday contact. Instead, the genetic transmission of Leukocyte adhesion deficiency type I happens when a child inherits two changed copies of the same gene, one from each parent.
Most parents are healthy carriers, which means they have one changed copy and one working copy and usually do not have the condition themselves. If both parents are carriers, each pregnancy has a 1 in 4 chance of resulting in a child with Leukocyte adhesion deficiency type I, a 1 in 2 chance of a child who is also a carrier, and a 1 in 4 chance of a child who inherits neither changed copy.
When to test your genes
Consider genetic testing for leukocyte adhesion deficiency type I when a baby has recurrent serious bacterial infections, delayed umbilical cord separation, poor wound healing, or little pus despite infection, especially with a family history. Early testing confirms the diagnosis, guides infection prevention and stem cell transplant planning, and helps with family planning.
Diagnosis
Leukocyte adhesion deficiency type I is usually suspected when a baby or child has repeated bacterial infections, slow wound healing, or delayed separation of the umbilical cord after birth. Doctors often piece the diagnosis together from this pattern, especially when infections happen without much pus despite clear inflammation. Getting a diagnosis is often a turning point toward answers and support. The genetic diagnosis of leukocyte adhesion deficiency type I is then confirmed with blood and genetic tests.
Doctors look closely at the history of frequent skin, mouth, or deep tissue infections, along with poor healing after cuts or procedures. Delayed umbilical cord separation and severe gum disease in early childhood can be important clues.
A complete blood count often shows very high white blood cell levels, especially during infections. This happens because infection-fighting cells are made normally but cannot move into tissues the usual way.
Doctors may perform flow cytometry, a blood test that measures proteins on the surface of white blood cells. In leukocyte adhesion deficiency type I, the CD18 protein is very low or absent, which strongly supports the diagnosis.
Genetic tests can confirm changes in the ITGB2 gene, which is the cause of leukocyte adhesion deficiency type I. This helps secure the diagnosis of leukocyte adhesion deficiency type I and may also guide family testing.
How is Leukocyte adhesion deficiency type i diagnosed?
Doctors usually suspect leukocyte adhesion deficiency type I in babies or children with repeated serious bacterial infections, slow healing, little or no pus, and often a belly button stump that takes longer than usual to fall off. Blood tests often show very high white blood cell counts, and a special lab test can check whether these cells are missing the surface markers they need to leave the bloodstream and reach an infection. Genetic testing can help confirm the diagnosis by finding the gene change that causes the condition.
Stages of Leukocyte adhesion deficiency type i
Leukocyte adhesion deficiency type I does not have defined progression stages. This is because it is a lifelong inherited immune disorder rather than an illness that moves through clear step-by-step phases over time. Often the process begins when you notice changes in daily life, such as a baby or child having repeated bacterial infections, slow wound healing, little or no pus at infected areas, or delayed separation of the umbilical cord, which are common early symptoms of leukocyte adhesion deficiency type I. Doctors usually confirm leukocyte adhesion deficiency type I with blood tests, including tests that measure certain white blood cell surface proteins, and then monitor it by tracking infections, healing, and overall health over time.
Outlook and prognosis
The outlook for leukocyte adhesion deficiency type I varies mainly with severity, especially the level of CD18 expression and how early treatment begins. Severe forms can cause recurrent, life-threatening bacterial and fungal infections starting in infancy, and without curative treatment many affected children have a high risk of early death, often within the first few years of life. Milder forms may allow survival into adolescence or adulthood, but chronic skin, gum, and wound-healing problems can still cause major illness. Hematopoietic stem cell transplantation can be curative and has greatly improved survival when performed early, particularly before repeated severe infections or organ damage occur. With modern supportive care, including prompt antibiotics and careful infection management, outcomes have improved, but prognosis remains guarded in severe untreated disease.
Long-term effects
Leukocyte adhesion deficiency type I can have serious long-term effects because infection-fighting white blood cells have trouble leaving the bloodstream and reaching injured or infected tissue. For many, this can mean repeated infections, slow healing, and inflammation that does not settle in the usual way. The long-term picture is often shaped by how severe the condition is and whether treatment changes the course early in life. When people ask about the long-term effects of leukocyte adhesion deficiency type I, doctors usually focus on infection burden, tissue damage, growth, and overall survival.
Many living with leukocyte adhesion deficiency type I have ongoing bacterial and fungal infections that can return again and again over time. These may affect the skin, lungs, mouth, or areas around the anus, and severe infections can become life-threatening.
Cuts, sores, and surgical wounds may heal poorly because white blood cells cannot move into tissue the way they should. Some may find that everyday injuries linger, with redness or skin breakdown that lasts much longer than expected.
Ongoing inflammation of the gums is a common long-term feature of leukocyte adhesion deficiency type I. Over time, this can lead to loose teeth, early tooth loss, and damage to the tissues that support the teeth.
Repeated skin infections and poor healing can leave scars and areas of chronic breakdown. Deep infections may also damage soft tissue underneath the skin and sometimes spread more widely through the body.
How is it to live with Leukocyte adhesion deficiency type i?
Living with leukocyte adhesion deficiency type I often means living with constant vigilance, because the immune system has trouble moving white blood cells to where they are needed, so even small cuts, mouth sores, or skin infections can become serious and may heal slowly. Many people with this condition need frequent medical visits, rapid treatment for fevers or infections, careful dental care, and sometimes limits around exposure to germs, which can disrupt school, work, travel, and everyday routines. For families and other close supports, this can mean extra planning, worry during illnesses, and the need to act quickly when symptoms appear, but with coordinated specialist care, many people can build safer routines and a more predictable daily life.
Treatment and drugs
Treatment for Leukocyte adhesion deficiency type I focuses on preventing and quickly treating infections, since the immune system has trouble getting white blood cells to the places they are needed. This often includes prompt antibiotics for bacterial infections, careful wound and dental care, and sometimes preventive antibiotics to lower the chance of repeated illness. For many people, the most effective long-term treatment for severe Leukocyte adhesion deficiency type I is a stem cell transplant, which aims to replace the faulty blood-forming cells with healthy ones. Supportive care can make a real difference in how you feel day to day, and doctors may also monitor nutrition, growth, and healing because skin sores and gum problems can be slow to improve. Finding the right therapy can take some time, especially because treatment depends on how severe Leukocyte adhesion deficiency type I is and how often infections happen.
Can you cure Leukocyte adhesion deficiency type i?
Leukocyte adhesion deficiency type 1 can sometimes be cured with a blood stem cell transplant, also called a bone marrow transplant, because it can replace the faulty infection-fighting cells with healthy ones. If a transplant is not possible, treatment focuses on preventing and quickly treating infections and caring for wounds, which can help people stay healthier but does not fix the root cause. Newer treatments are being studied, but they are not yet standard care.
Non-drug treatment
Daily care for people with Leukocyte adhesion deficiency type I often centers on preventing infections, protecting the skin and mouth, and watching closely for wounds that heal slowly. Because this condition can cause severe, repeated infections from early life, treatment usually involves both supportive care and, when possible, a procedure aimed at correcting the immune problem. Managing this condition often means working with a team that may include immunology, infectious disease, dentistry, wound care, and transplant specialists.
A hematopoietic stem cell transplant is the main non-drug treatment that can correct the underlying immune defect in Leukocyte adhesion deficiency type I. It replaces the faulty blood-forming cells with healthy donor cells, with the goal of reducing severe infections over time.
Careful cleaning, dressing changes, and regular checks of cuts or sores can help lower the risk of infection and support healing. This is especially important because early symptoms of Leukocyte adhesion deficiency type I often include wounds that heal slowly or skin infections that keep coming back.
Gentle daily oral care and regular dental visits are a key part of treatment, since gum inflammation and severe mouth infections are common. Professional cleaning and early treatment of irritated gums can help protect teeth and make eating more comfortable.
Good handwashing, skin hygiene, and avoiding exposure to people with contagious illnesses can help reduce everyday infection risks. Families are often taught to seek medical attention quickly for fever, skin redness, or other signs that an infection may be starting.
Your genes may have an impact on how drugs work for you
For people living with leukocyte adhesion deficiency type 1, treatment usually centers on preventing and treating infections and, in some cases, a bone marrow or stem cell transplant, so day-to-day medicine choices are guided more by how severe the condition is than by usual differences in how the body handles drugs. The gene change that causes this condition mainly affects how white blood cells move and fight germs, and it is not widely known to change the response to the antibiotics or other supportive medicines commonly used. Before a transplant, though, doctors may still look closely at how someone is likely to respond to strong treatment medicines, because side effects and dosing can vary from person to person even if this is not the main issue in this condition.
Pharmacological treatments
In leukocyte adhesion deficiency type I, medicines mainly help prevent or treat infections rather than fix the underlying immune problem. Drug treatments are not about fixing everything at once, but about controlling bacterial and fungal infections quickly and lowering the risk of serious complications. For many living with leukocyte adhesion deficiency type I, early treatment of infections is a central part of day-to-day care.
Broad-spectrum antibiotics such as cefepime, piperacillin-tazobactam, meropenem, or vancomycin may be used when a serious infection is suspected. These drugs are chosen based on the likely source of infection, local resistance patterns, and culture results.
Trimethoprim-sulfamethoxazole is often used to help prevent repeated bacterial infections in some people with leukocyte adhesion deficiency type I. The exact plan depends on how severe the condition is and how often infections happen.
Medicines such as fluconazole, voriconazole, or amphotericin B may be used if fungal infection is suspected or confirmed. This can matter when fever does not settle, wounds are slow to heal, or there have been prior fungal infections.
Mupirocin or similar skin treatments may be used for small infected areas around the skin or nose. They are usually added to, not used instead of, full treatment when infections run deeper or spread.
Genetic influences
Leukocyte adhesion deficiency type I happens because of changes in the ITGB2 gene, which helps white blood cells stick to blood vessel walls and move into tissues to fight infection. When both copies of this gene are not working properly, these cells cannot travel where they are needed, which is why people with leukocyte adhesion deficiency type I can have severe infections and slow wound healing. This condition is inherited in an autosomal recessive pattern, so a child develops it only after receiving one nonworking copy from each parent. A carrier means you hold the gene change but may not show symptoms, so parents are often healthy and may not know they carry it. Genetic testing can confirm the genetic causes of leukocyte adhesion deficiency type I and help relatives understand their own chances of being carriers or having another affected child.
Is Leukocyte adhesion deficiency type i genetic?
Genetics are central to Leukocyte adhesion deficiency type I. It is caused by changes in the ITGB2 gene, and the exact variant can influence how severe symptoms are and help guide genetic testing and family counseling.
Having a genetic risk is not necessarily a diagnosis
Changes in genes are a normal part of being human and are common across the general population. Most of these changes do not directly affect health and simply reflect natural differences among people. For many genes, having a change tied to a condition suggests a possible link rather than a certain diagnosis, especially when several genes and environmental factors play a role. In some situations, though, one well-studied change in a specific gene is enough to confirm a diagnosis.
Pharmacogenetics—how genetics influence drug effects
For many living with leukocyte adhesion deficiency type I, the same genetic result that helps explain the early symptoms of leukocyte adhesion deficiency type I also helps doctors judge how severe the condition may be. In leukocyte adhesion deficiency type I, changes in the ITGB2 gene affect a white blood cell protein called CD18, and the amount of working CD18 can help guide decisions about how quickly to move toward a stem cell transplant, which is the main treatment that can correct the immune problem. Not every difference in response is genetic, but there is no standard gene-based test used to predict which antibiotic or antifungal medicine will work best specifically for leukocyte adhesion deficiency type I. Instead, these drugs are usually chosen based on the type of infection, lab culture results, prior side effects, and how well the liver and kidneys are working. Families may also hear about gene therapy in specialized centers or research studies, where the goal is to add a working copy of the faulty gene.
Interactions with other conditions
For people living with leukocyte adhesion deficiency type I, the biggest day-to-day issue is often not the condition by itself but the repeated infections and slow healing that can trigger other serious health problems. Another important aspect is how it may link with other diseases. Leukocyte adhesion deficiency type I can lead to frequent bacterial and fungal infections of the skin, lungs, mouth, and other tissues, and these infections may progress to sepsis, a dangerous body-wide reaction to infection. Many living with leukocyte adhesion deficiency type I also develop severe gum disease early in life, and some can have bowel inflammation that looks a lot like inflammatory bowel disease, which can make diagnosis less straightforward. Because the early symptoms of leukocyte adhesion deficiency type I can resemble common infections or delayed wound healing from other causes, doctors often look closely at the pattern of illness rather than any one symptom alone. With prompt treatment of infections and careful follow-up from immune and infection specialists, many complications can be recognized earlier and managed more safely.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
What other conditions can cause similar symptoms to Leukocyte adhesion deficiency type i?
Other rare immune system problems can look a lot like leukocyte adhesion deficiency type I, especially conditions where white blood cells are too low or cannot kill germs well, such as severe neutropenia and chronic granulomatous disease. Doctors may also consider other types of leukocyte adhesion deficiency and, in some babies, severe combined immune deficiency, because these can also cause repeated serious infections, mouth sores, poor wound healing, and a delayed falling-off of the umbilical cord.
History
Children with leukocyte adhesion deficiency type I often come to medical attention because everyday infections do not behave the way families expect. A cut may heal slowly, skin infections can keep coming back, and there may be little or no pus even when an infection is clearly present. These unusual patterns led doctors to realize that the problem was not just frequent infection, but a deeper issue with how white blood cells move to sites of injury and infection.
Leukocyte adhesion deficiency type I was first recognized as a distinct condition in the 1970s, when doctors described infants and young children with severe bacterial infections, delayed wound healing, and separation of the umbilical cord later than usual. At first, the condition was understood mainly through these striking symptoms and through laboratory findings showing very high numbers of white blood cells in the bloodstream. In recent decades, awareness has grown, and researchers were able to show that in leukocyte adhesion deficiency type I, infection-fighting cells are present but cannot attach and travel out of the blood vessels the way they should.
That shift mattered because it changed leukocyte adhesion deficiency type I from a puzzling infection disorder into a better-understood immune condition. From these first observations, scientists developed more accurate testing and clearer ways to tell it apart from other causes of repeated infections in babies and children. Today, the history of leukocyte adhesion deficiency type I helps explain why early symptoms of leukocyte adhesion deficiency type I can look unusual, and why quick recognition is so important for treatment and long-term care.